Richard Buchholz Inspire Medical Systems, Inc. (INSP) insider trading activity

Richard Buchholz is Chief Financial Officer of Inspire Medical Systems, Inc.. Currently has a direct ownership of 44,867 shares of INSP, which is worth approximately $3.47 Million. The most recent transaction as insider was on Aug 29, 2025, when has been sold 11,000 shares (Common Stock) at a price of $93.39 per share, resulting in proceeds of $1,027,290. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.9K

24.2% 3M change

61.56% 12M change

Total Value Held $3.47 Million

Richard Buchholz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 29 2025	SELL Open market or private sale	$1,027,290 $93.39 p/Share	11,000 Reduced 19.69%	44,867 Common Stock
Aug 19 2025	SELL Payment of exercise price or tax liability	$485,491 $90.24 p/Share	5,380 Reduced 8.78%	55,867 Common Stock
Aug 19 2025	BUY Exercise of conversion of derivative security	$1,414,952 $56.58 p/Share	25,008 Added 28.99%	61,247 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$410,190 $186.45 p/Share	2,200 Reduced 5.74%	36,126 Common Stock
Feb 24 2025	BUY Grant, award, or other acquisition	-	6,152 Added 13.83%	38,326 Common Stock
Feb 21 2025	SELL Bona fide gift	-	500 Reduced 1.53%	32,174 Common Stock
Feb 13 2025	BUY Grant, award, or other acquisition	-	5,076 Added 13.45%	32,674 Common Stock
Feb 09 2025	SELL Payment of exercise price or tax liability	$57,195 $182.15 p/Share	314 Reduced 1.12%	27,598 Common Stock
Apr 17 2024	SELL Open market or private sale	$3,450,450 $230.03 p/Share	15,000 Reduced 34.67%	28,271 Common Stock
Apr 17 2024	SELL Bona fide gift	-	500 Reduced 1.77%	27,771 Common Stock
Feb 09 2024	BUY Grant, award, or other acquisition	-	2,694 Added 5.86%	43,271 Common Stock
Jan 25 2023	BUY Exercise of conversion of derivative security	$251,198 $41.18 p/Share	6,100 Added 13.09%	40,487 Common Stock
Jan 13 2023	SELL Open market or private sale	$2,994,609 $250.03 p/Share	11,977 Reduced 25.83%	34,387 Common Stock
Jan 11 2023	SELL Open market or private sale	$130,750 $250.0 p/Share	523 Reduced 1.12%	46,364 Common Stock
Jan 05 2023	SELL Bona fide gift	-	400 Reduced 0.85%	46,887 Common Stock
Apr 01 2022	SELL Open market or private sale	$3,869,400 $257.96 p/Share	15,000 Reduced 24.13%	47,176 Common Stock
Feb 18 2022	SELL Bona fide gift	-	250 Reduced 0.4%	62,176 Common Stock
Feb 17 2022	SELL Bona fide gift	-	250 Reduced 0.4%	62,426 Common Stock
Sep 28 2021	BUY Exercise of conversion of derivative security	$84,734 $17.82 p/Share	4,755 Added 7.06%	62,624 Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	$313,500 $25.08 p/Share	12,500 Added 17.78%	57,789 Common Stock
Feb 25 2021	SELL Open market or private sale	$4,522,200 $226.11 p/Share	20,000 Reduced 30.41%	45,769 Common Stock
Jan 21 2021	SELL Bona fide gift	-	480 Reduced 1.05%	45,289 Common Stock
Dec 15 2020	SELL Open market or private sale	$567,060 $189.02 p/Share	3,000 Reduced 4.37%	65,651 Common Stock
Nov 17 2020	SELL Open market or private sale	$511,530 $170.51 p/Share	3,000 Reduced 4.19%	68,651 Common Stock
Oct 20 2020	SELL Open market or private sale	$367,020 $122.34 p/Share	3,000 Reduced 4.02%	71,651 Common Stock

Also insider at

SHOULDER INNOVATIONS, INC.

Director